ClinicalTrialsFinder

Unresectable Gastroesophageal Junction Adenocarcinoma Clinical Trials in Oklahoma City, Oklahoma

1 recruitingOklahoma City, Oklahoma

Showing 1–1 of 1 trials

Recruiting
Phase 1

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast Carcinoma+37 more
National Cancer Institute (NCI)51 enrolled23 locationsNCT04704661